Dr. Kinzler is the Study Director for Drugscan’s CAT.one in vitro testing program. He brings more than 15 years of experience in late-stage product development and commercialization in the pharmaceutical industry.
Dr. Kinzler has been focused on the development of products for pain management since 2007 and has assisted Sponsors with in vitro testing, regulatory submission, and pre-commercial planning for several investigational and FDA-approved products with abuse-deterrent labeling.
Dr. Kinzler earned his doctorate in Cellular and Molecular Biology at the University of Wisconsin. He graduated with honors from the University of Colorado at Boulder.